Lin Zhou
- Hepatology top 0.5%
- Liver Disease and Transplantation 44
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Cancer Research top 0.5%
- Transplantation top 1%
- Oncology top 1%
- Molecular Biology top 1%
- RNA modifications and cancer 19
-
- Organ Transplantation Techniques and Outcomes 50
-
- Liver Disease Diagnosis and Treatment 41
- Hepatitis B Virus Studies 19
-
- Immunotherapy and Immune Responses 19
- Immune Cell Function and Interaction 16
- Co-authors
- Shusen ZhengHaiyang XieJian WuXiao XuShengyong YinJiacheng HuangYiting QiaoShengzhang Lin
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Lin Zhou
289 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hepatology 1.4k
- Cancer Research 1.9k
- Transplantation 244
- Oncology 2.0k
- Molecular Biology 4.6k
Countries citing papers authored by Lin Zhou
This map shows the geographic impact of Lin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhou more than expected).
Fields of papers citing papers by Lin Zhou
This network shows the impact of papers produced by Lin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhou. The network helps show where Lin Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 13 | |
| 3 | 2023 | 14 | |
| 4 | 2023 | 33 | |
| 5 | Extracellular matrix and its therapeutic potential for cancer treatmentbreakdown → | 2021 | 580 |
| 6 | 2021 | 3 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 3 | |
| 9 | Clinical analysis on safety and efficacy of ICG real-time fluorescence imaging in laparoscopic hepatectomy of HCC at special location | 2019 | 2 |
| 10 | 2018 | 46 | |
| 11 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinomabreakdown → | 2018 | 543 |
| 12 | 2018 | 1 | |
| 13 | 2017 | 133 | |
| 14 | 2017 | 84 | |
| 15 | 2014 | 8 | |
| 16 | 2013 | 41 | |
| 17 | 2013 | 18 | |
| 18 | 2012 | 23 | |
| 19 | No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation. | 2007 | 8 |
| 20 | Fast detection of human cytomegalovirus and differentiation of glycoprotein B and H genotypes by PCR- assisted reverse hybridization | 2002 | 1 |
About Lin Zhou
Lin Zhou is a scholar working on Hepatology, Transplantation and Immunology, having authored 300 papers that have together received 9.2k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (50 papers), Liver Disease and Transplantation (44 papers), Liver Disease Diagnosis and Treatment (41 papers), Hepatocellular Carcinoma Treatment and Prognosis (28 papers), RNA modifications and cancer (19 papers), Hepatitis B Virus Studies (19 papers), Immunotherapy and Immune Responses (19 papers) and Immune Cell Function and Interaction (16 papers). The work is most often cited by research in Hepatology (1.4k citations), Cancer Research (1.9k citations) and Transplantation (244 citations). Lin Zhou has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Shusen Zheng, Haiyang Xie, Jian Wu, Xiao Xu, Shengyong Yin, Jiacheng Huang, Shusen Zheng, Yiting Qiao, Shengzhang Lin and Dalong Wan. Their work appears in journals such as PLoS ONE, Cancer Letters, Journal of Translational Medicine, International Journal of Biological Sciences and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.